In 2023, we completed the (NIBRT) expansion enabling increased capacity and capability to conduct manufacturing-focused research and training in advanced therapeutics such as cell therapies, gene therapies, mRNA and other novel vaccines.
This was our second project with NIBRT, having worked on the original building over a decade ago.
A 65,000m2 facility built as a medium-scale bio-processing plant comprising seven research laboratories, a bio-processing pilot plant and training / office facilities completed in 2011 at a value of €13.5m.
NIBRT which is part funded by the IDA Ireland, has a remit to support the development of the existing bioprocessing industry in Ireland and to attract additional bioprocessing companies to Ireland by:
- Training highly skilled personnel for the bioprocessing industry.
- Conducting world-class research in key areas of bioprocessing.
- Providing a critical mass of multipurpose bioprocessing facilities.